HCV : burden of disease

HCV HIV

Prevalence world-wide 3% (300.106) 0.34% (34.106) x9

USA 1.8% (4.106) 0.6% (1.106) x4

France 1.2% (600.103) 0.44% (200.103) x3

Belgium 1% ? (100.103) 0.15% (15.103) x7

Peak prevalence 40-49 y.o. 30-40 y.o.

Annual related † USA (2001) 10.000 18.000

France (1997) 3.000 1.300 x2.3

Annual incidence/year

France (1997) 20.103 700 x28

Funding/year USA 4.5.106$ 1.15 billions $ ?366

Deufic et al., Hepatology 2001, A199

OMS 1999

cdc.gov website

Previous slide

Next slide

Back to first slide

View graphic version